Finance

Lists
471820:KOSDAQ
Cellromax Science Co Ltd
â‚İ4,060.00
-0.73%
(-30.00) 1D
Jul 24, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 471820...
Open
â‚İ4,005
High
â‚İ4,095
Low
â‚İ3,995
Mkt. cap
45.89B
Avg. vol.
6.77K
Volume
7.28K
Dividend
4.56%
Quarterly dividend
â‚İ46
Ex-dividend date
Jun 29, 2026
P/E ratio
13.46
52-wk high
â‚İ7,690
52-wk low
â‚İ3,945
EPS
â‚İ302
Shares outstanding
11.30M
No. of employees
52
Open
â‚İ4,005
High
â‚İ4,095
Low
â‚İ3,995
Mkt. cap
45.89B
Avg. vol.
6.77K
Volume
7.28K
Dividend
4.56%
Quarterly dividend
â‚İ46
Ex-dividend date
Jun 29, 2026
P/E ratio
13.46
52-wk high
â‚İ7,690
52-wk low
â‚İ3,945
EPS
â‚İ302
Shares outstanding
11.30M
No. of employees
52
News stories
From sources across the web
About Cellromax Science Co Ltd
CEO-
Employees52
Founded2014
Headquarters-
SectorCapital market
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.46B
5.33B
4.48B
4.71B
Cost of goods sold
3.33B
2.64B
2.67B
2.20B
Cost of revenue
3.33B
2.64B
2.67B
2.20B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.82B
1.79B
1.57B
2.00B
Operating expense
1.97B
1.96B
1.72B
2.15B
Total operating expenses
5.30B
4.60B
4.39B
4.36B
Operating income
1.16B
736.75M
86.39M
348.45M
Other non operating income
-28.47M
-43.01M
13.08M
123.54M
EBT including unusual items
1.47B
947.49M
98.65M
644.18M
EBT excluding unusual items
1.44B
901.03M
72.95M
618.39M
Income tax expense
317.77M
190.12M
-216.53M
-546.81M
Effective tax rate
21.58%
20.07%
-219.49%
-84.89%
Other operating expenses
26.30M
45.70M
32.01M
33.96M
Net income
1.15B
757.37M
315.18M
1.19B
Net profit margin
17.88%
14.20%
7.04%
25.31%
Earnings per share
-
-
-
-
Interest and investment income
332.33M
216.18M
-
151.80M
Interest expense
-17.44M
-9.48M
-26.32M
-5.38M
Net interest expenses
314.89M
206.70M
-26.32M
146.42M
Depreciation and amortization charges
118.95M
119.13M
118.18M
112.64M
EBITDA
1.28B
856.81M
206.64M
465.36M
Gain or loss from assets sale
-
-4.64M
-6.18M
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more